HCV reinfection incidence among individuals treated for recent infection

Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies

(2016) Marianne Martinello et al.   ANTIVIRAL THERAPY

Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights

(2016) Natasha K. Martin et al.   CLINICAL INFECTIOUS DISEASES

Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis

(2016) Bryony Simmons et al.   CLINICAL INFECTIOUS DISEASES

Illicit drug use and its association with sexual risk behaviour among MSM

(2016) G.J. Melendez-Torres et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs

(2016) Amanda Weir et al.   DRUG AND ALCOHOL DEPENDENCE

Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections

(2016) Edward J. Gane et al.   GASTROENTEROLOGY

Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model

(2016) Nick Scott et al.   GUT

Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions

(2016) Luisa Salazar-Vizcaya et al.   HEPATOLOGY

Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II study

(2016) Marianne Martinello et al.   HEPATOLOGY

Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis

(2016) Ashly E Jordan et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Trends in Serosorting and the Association With HIV/STI Risk Over Time Among Men Who Have Sex With Men

(2016) Christine M. Khosropour et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

(2016) Natasha K. Martin et al.   JOURNAL OF HEPATOLOGY

Hepatitis C reinfection after sustained virological response

(2016) Håvard Midgard et al.   JOURNAL OF HEPATOLOGY

Modelling the impact of deferring HCV treatment on liver-related complications in HIV coinfected men who have sex with men

(2016) Cindy Zahnd et al.   JOURNAL OF HEPATOLOGY

Clinicians' Views of Hepatitis C Virus Treatment Candidacy With Direct-Acting Antiviral Regimens for People Who Inject Drugs

(2016) Alice K. Asher et al.   SUBSTANCE USE & MISUSE

Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men

(2015) Holly Hagan et al.   AIDS

Hepatitis C Virus Therapeutic Development: In Pursuit of "Perfectovir"

(2015) G. J. Dore et al.   CLINICAL INFECTIOUS DISEASES

Hepatitis C virus treatment as prevention in people who inject drugs

(2015) Matthew Hickman et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006–2013

(2015) Ashly E. Jordan et al.   DRUG AND ALCOHOL DEPENDENCE

Sexual and prevention practices in men who have sex with men in the era of combination HIV prevention: results from the Presse Gays et Lesbiennes survey, France, 2011

(2015) A Velter et al.   Eurosurveillance

Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs

(2015) Anthony Cousien et al.   HEPATOLOGY

Risk Factors for HCV Acquisition Among HIV-Positive MSM in Belgium

(2015) Ludwig Apers et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Mixed HCV infection and reinfection in people who inject drugs—impact on therapy

(2015) Evan B. Cunningham et al.   Nature Reviews Gastroenterology & Hepatology

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

(2015) Jordan J. Feld et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

(2015) Susanna Naggie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sex, drugs and smart phone applications: findings from semistructured interviews with men who have sex with men diagnosed withShigella flexneri3a in England and Wales: Table 1

(2015) V L Gilbart et al.   SEXUALLY TRANSMITTED INFECTIONS

Novel Interventions to Prevent HIV and HCV Among Persons Who Inject Drugs

(2015) Phillip O. Coffin et al.   Current HIV/AIDS Reports

Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial

(2015) Jürgen K Rockstroh et al.   Lancet HIV

The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis

(2015) François M. J. Lamoury et al.   PLoS One

The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users

(2014) Seonaid Nolan et al.   ADDICTION

Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada

(2014) Brendan Jacka et al.   HEPATOLOGY

Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance

(2014) P Ingiliz et al.   HIV MEDICINE

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact

(2014) N. K. Martin et al.   JOURNAL OF VIRAL HEPATITIS

Acute hepatitis C infection in HIV-negative men who have sex with men

(2014) K. McFaul et al.   JOURNAL OF VIRAL HEPATITIS

Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study

(2014) Bethany White et al.   MEDICAL JOURNAL OF AUSTRALIA

Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug Users

(2014) Judith I. Tsui et al.   JAMA Internal Medicine

Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM

(2013) Thomas C.S. Martin et al.   AIDS

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy

(2013) Natasha K. Martin et al.   CLINICAL INFECTIOUS DISEASES

Treatment of Hepatitis C Virus Infection Among People Who Are Actively Injecting Drugs: A Systematic Review and Meta-analysis

(2013) Esther J. Aspinall et al.   CLINICAL INFECTIOUS DISEASES

Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C

(2013) A. Marco et al.   JOURNAL OF HEPATOLOGY

The Cedar Project: high incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities

(2012) Patricia M Spittal et al.   BMC PUBLIC HEALTH

The More You Look, the More You Find: Effects of Hepatitis C Virus Testing Interval on Reinfection Incidence and Clearance and Implications for Future Vaccine Study Design

(2012) Peter Vickerman et al.   JOURNAL OF INFECTIOUS DISEASES

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence

(2011) Katy M. E. Turner et al.   ADDICTION

Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM

(2011) Femke A.E. Lambers et al.   AIDS

Incidence of Hepatitis-C among HIV infected men who have sex with men (MSM) attending a sexual health service: a cohort study

(2011) Deepa G Gamage et al.   BMC INFECTIOUS DISEASES

Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection

(2011) Jason Grebely et al.   HEPATOLOGY

Preexposure Prophylaxis and Predicted Condom Use Among High-Risk Men Who Have Sex With Men

(2010) Sarit A Golub et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Reinfection with hepatitis C virus following sustained virological response in injection drug users

(2010) Jason Grebely et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection

(2009) Gregory J. Dore et al.   GASTROENTEROLOGY

Meta-Regression of Hepatitis C Virus Infection in Relation to Time Since Onset of Illicit Drug Injection: The Influence of Time and Place

(2008) H. Hagan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus

(2007) Sue L. Currie et al.   DRUG AND ALCOHOL DEPENDENCE